DNLI

Denali Therapeutics
DNLI

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.05B
EV
$1.05B
Shares Outstanding
171.30M
Beta
1.33

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$32.19
P/E 2025E
-
P/Revenue 2025E
99.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Denali Therapeutics Inc.

gainify
DNLI

Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company’s transport vehicle (TV)-enabl...

Sector

Healthcare

Industry

Biotechnology

CEO

Watts, Ryan

Employees

443

IPO Date

2017-12-08

Headquarters

161 Oyster Point Boulevard, South San Francisco, California, 94080, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.